Publication | Open Access

Novel C-Terminal Hsp90 Inhibitor for Head and Neck Squamous Cell Cancer (HNSCC) with in vivo Efficacy and Improved Toxicity Profiles Compared with Standard Agents

OncologyMedicineTreatment ResistanceStandard AgentsPathologyVivo EfficacyHead And Neck CancerAnti-cancer AgentCancer TreatmentNeck OncologyPharmacologyCancer ResearchTumor Biology